• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Coronary Artery Calcium Density and Cardiovascular Events by Volume Level: The MESA.冠状动脉钙密度与容积水平的心血管事件:MESA 研究。
Circ Cardiovasc Imaging. 2023 Feb;16(2):e014788. doi: 10.1161/CIRCIMAGING.122.014788. Epub 2023 Feb 21.
2
Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study.2 型糖尿病患者的冠状动脉钙、肝脂肪变性和动脉粥样硬化性心血管疾病风险:达拉斯心脏研究的结果。
Prog Cardiovasc Dis. 2023 May-Jun;78:67-73. doi: 10.1016/j.pcad.2023.03.002. Epub 2023 Mar 15.
3
The effectiveness and cost-effectiveness of computed tomography screening for coronary artery disease: systematic review.计算机断层扫描筛查冠心病的有效性和成本效益:系统评价
Health Technol Assess. 2006 Oct;10(39):iii-iv, ix-x, 1-41. doi: 10.3310/hta10390.
4
The prognostic interplay of coronary artery calcium volume and density with myocardial flow reserve and incident cardiovascular events.冠状动脉钙化体积和密度与心肌血流储备及心血管事件发生之间的预后相互作用。
Eur Heart J Cardiovasc Imaging. 2025 Jun 30;26(7):1176-1183. doi: 10.1093/ehjci/jeaf143.
5
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
6
Polygenic Risk Scores and Extreme Coronary Artery Calcium Phenotypes (CAC=0 and CAC≥1000) in Adults ≥75 Years Old: The ARIC Study.多基因风险评分与≥75 岁成年人的极重度冠状动脉钙表型(CAC=0 和 CAC≥1000):ARIC 研究。
Circ Cardiovasc Imaging. 2024 Nov;17(11):e016377. doi: 10.1161/CIRCIMAGING.123.016377. Epub 2024 Nov 13.
7
Quantitative analysis of small coronary artery calcium detectability with an accurate simulation and validation on a clinical CT scanner.采用准确模拟和临床 CT 扫描仪验证方法对小冠状动脉钙化的可探测性进行定量分析。
Med Phys. 2023 Oct;50(10):6060-6070. doi: 10.1002/mp.16652. Epub 2023 Jul 31.
8
A systematic review and economic evaluation of statins for the prevention of coronary events.他汀类药物预防冠状动脉事件的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. doi: 10.3310/hta11140.
9
Progression of Coronary Artery Calcification and Risk of Clinical Events in CKD: The Chronic Renal Insufficiency Cohort Study.慢性肾脏病患者冠状动脉钙化进展与临床事件风险:慢性肾功能不全队列研究
Am J Kidney Dis. 2025 Jan;85(1):67-77.e1. doi: 10.1053/j.ajkd.2024.06.018. Epub 2024 Aug 16.
10
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复。
Cochrane Database Syst Rev. 2021 Nov 6;11(11):CD001800. doi: 10.1002/14651858.CD001800.pub4.

引用本文的文献

1
Coronary Artery Calcium Distribution and Cardiovascular Risk: MESA.冠状动脉钙化分布与心血管风险:多族裔动脉粥样硬化研究(MESA)
JACC Cardiovasc Imaging. 2025 Mar;18(3):392-394. doi: 10.1016/j.jcmg.2024.10.005. Epub 2024 Dec 4.
2
Beyond the Agatston calcium score: role of calcium density and other calcified plaque markers for cardiovascular disease prediction.超越阿加斯顿钙评分:钙密度及其他钙化斑块标志物在心血管疾病预测中的作用
Curr Opin Cardiol. 2025 Jan 1;40(1):56-62. doi: 10.1097/HCO.0000000000001185. Epub 2024 Oct 9.
3
Analysis of risk factors for PCI no-reflow in coronary heart disease and construction of related prediction models.冠心病经皮冠状动脉介入治疗无复流的危险因素分析及相关预测模型的构建
Am J Transl Res. 2024 Aug 15;16(8):3733-3741. doi: 10.62347/ECNI6080. eCollection 2024.
4
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies.无症状人群体内亚临床动脉粥样硬化的评估:适合生物标志物和孟德尔随机化研究的测量方法。
Arterioscler Thromb Vasc Biol. 2024 Jan;44(1):24-47. doi: 10.1161/ATVBAHA.123.320138. Epub 2023 Nov 21.
5
Coronary Artery Calcium Scoring in Asymptomatic Patients.无症状患者的冠状动脉钙化评分
HCA Healthc J Med. 2023 Oct 30;4(5):341-352. doi: 10.36518/2689-0216.1565. eCollection 2023.
6
Association of apolipoproteins C-I and C-II truncations with coronary heart disease and progression of coronary artery calcium: Multi-Ethnic Study of Atherosclerosis.载脂蛋白 C-I 和 C-II 截断与冠心病及冠状动脉钙进展的相关性:动脉粥样硬化多民族研究。
Atherosclerosis. 2023 Sep;380:117214. doi: 10.1016/j.atherosclerosis.2023.117214. Epub 2023 Aug 7.

本文引用的文献

1
Evolving Role of Calcium Density in Coronary Artery Calcium Scoring and Atherosclerotic Cardiovascular Disease Risk.钙密度在冠状动脉钙化积分和动脉粥样硬化性心血管疾病风险中的作用演变。
JACC Cardiovasc Imaging. 2022 Sep;15(9):1648-1662. doi: 10.1016/j.jcmg.2022.02.026. Epub 2022 May 11.
2
How Should We Measure and Score Coronary Artery Calcium?我们应该如何测量和评分冠状动脉钙化?
JACC Cardiovasc Imaging. 2022 Mar;15(3):501-503. doi: 10.1016/j.jcmg.2021.11.004. Epub 2021 Dec 15.
3
Mean Versus Peak Coronary Calcium Density on Non-Contrast CT: Calcium Scoring and ASCVD Risk Prediction.平扫 CT 冠状动脉钙密度的均值与峰值:钙评分与 ASCVD 风险预测。
JACC Cardiovasc Imaging. 2022 Mar;15(3):489-500. doi: 10.1016/j.jcmg.2021.09.018. Epub 2021 Nov 17.
4
Physical activity and the progression of coronary artery calcification.体力活动与冠状动脉钙化进展。
Heart. 2021 Nov;107(21):1710-1716. doi: 10.1136/heartjnl-2021-319346. Epub 2021 Sep 20.
5
Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque Composition.他汀类药物治疗与冠状动脉粥样硬化斑块成分进展的关系。
JAMA Cardiol. 2021 Nov 1;6(11):1257-1266. doi: 10.1001/jamacardio.2021.3055.
6
Impact of Plaque Burden Versus Stenosis on Ischemic Events in Patients With Coronary Atherosclerosis.斑块负荷与狭窄对冠状动脉粥样硬化患者缺血事件的影响。
J Am Coll Cardiol. 2020 Dec 15;76(24):2803-2813. doi: 10.1016/j.jacc.2020.10.021.
7
Prognostic value of coronary artery calcium score, area, and density among individuals on statin therapy vs. non-users: The coronary artery calcium consortium.他汀类药物治疗使用者与非使用者中冠状动脉钙化评分、面积和密度的预后价值:冠状动脉钙化协会
Atherosclerosis. 2021 Jan;316:79-83. doi: 10.1016/j.atherosclerosis.2020.10.009. Epub 2020 Oct 10.
8
Association of High-Density Calcified 1K Plaque With Risk of Acute Coronary Syndrome.高密度钙化 1K 斑块与急性冠状动脉综合征风险的相关性。
JAMA Cardiol. 2020 Mar 1;5(3):282-290. doi: 10.1001/jamacardio.2019.5315.
9
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17.
10
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018 年美国心脏病学会/美国心脏协会/美国心血管血管造影和介入学会/美国预防、物理治疗和康复医师学会/美国糖尿病协会/美国老年学会/美国药学会/美国医师协会/美国生理学会/北美介入放射学会/美国国家脂质协会/美国临床内分泌医师协会胆固醇管理指南:美国心脏病学会/美国心脏协会临床实践指南工作组的报告。
Circulation. 2019 Jun 18;139(25):e1082-e1143. doi: 10.1161/CIR.0000000000000625. Epub 2018 Nov 10.

冠状动脉钙密度与容积水平的心血管事件:MESA 研究。

Coronary Artery Calcium Density and Cardiovascular Events by Volume Level: The MESA.

机构信息

Division of Cardiology, Department of Medicine (H.S.B., M.H.C.), University of California, San Diego, La Jolla.

Department of Biostatistics, University of Washington, Seattle (R.L.M.).

出版信息

Circ Cardiovasc Imaging. 2023 Feb;16(2):e014788. doi: 10.1161/CIRCIMAGING.122.014788. Epub 2023 Feb 21.

DOI:10.1161/CIRCIMAGING.122.014788
PMID:36802448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10191167/
Abstract

BACKGROUND

The Agatston coronary artery calcium (CAC) score provides robust cardiovascular disease risk prediction but upweights plaque area by a density factor. Density, however, has been shown to be inversely associated with events. Using CAC volume and density separately improves risk prediction, but it is unclear how to apply this method clinically. We aimed to evaluate the association between CAC density and cardiovascular disease across the spectrum of CAC volume to better understand how to incorporate these metrics into a single score.

METHODS

We performed an analysis of MESA (Multi-Ethnic Study of Atherosclerosis) participants with detectable CAC to evaluate the association between CAC density and events by level of CAC volume using multivariable Cox regression models.

RESULTS

In a cohort of 3316 participants, there was a significant interaction (<0.001) between CAC volume and density for coronary heart disease (CHD) risk (myocardial infarction, CHD death, resuscitated cardiac arrest). Models using CAC volume and density resulted in improvement in the -index (0.703, SE 0.012 versus 0.687, SE 0.013) and a significant net reclassification improvement (0.208 [95% CI, 0.102-0.306]) compared with the Agatston score for CHD risk prediction. Density was significantly associated with lower CHD risk at volumes ≤130 mm (hazard ratio, 0.57 per unit of density [95% CI, 0.43-0.75]), but the inverse association at volumes >130 mm was not significant (hazard ratio, 0.82 per unit of density [95% CI, 0.55-1.22]).

CONCLUSIONS

The lower risk for CHD associated with higher CAC density varied by level of volume, and volume ≤130 mm is a potentially clinically useful cut point. Further study is needed to integrate these findings into a unified CAC scoring method.

摘要

背景

Agatston 冠状动脉钙(CAC)评分可提供强大的心血管疾病风险预测,但通过密度因素对斑块面积进行加权。然而,密度已被证明与事件呈反比相关。单独使用 CAC 体积和密度可以提高风险预测,但尚不清楚如何将这种方法应用于临床。我们旨在评估 CAC 密度与 CAC 体积谱范围内的心血管疾病之间的关联,以更好地了解如何将这些指标纳入单个评分。

方法

我们对可检测到 CAC 的 MESA(动脉粥样硬化的多民族研究)参与者进行了分析,以使用多变量 Cox 回归模型评估 CAC 密度与 CAC 体积水平之间的关联与事件。

结果

在 3316 名参与者的队列中,CAC 体积和密度之间存在显著的相互作用(<0.001),用于评估冠心病(心肌梗死、冠心病死亡、复苏性心脏骤停)的风险。使用 CAC 体积和密度的模型导致 -指数的改善(0.703,SE 0.012 与 0.687,SE 0.013)和显著的净重新分类改善(0.208 [95%CI,0.102-0.306])与 Agatston 评分相比,用于冠心病风险预测。在体积≤130mm 时,密度与较低的冠心病风险显著相关(密度每单位的风险比为 0.57[95%CI,0.43-0.75]),但在体积>130mm 时,反比关系不显著(密度每单位的风险比为 0.82[95%CI,0.55-1.22])。

结论

与 CAC 密度较高相关的冠心病风险较低,其差异与体积水平有关,体积≤130mm 是一个潜在的临床有用的切点。需要进一步研究将这些发现纳入统一的 CAC 评分方法。